Neuropsychological impairment and decreased regional cerebral blood flow by interferon treatment in patients with chronic hepatitis: A preliminary study

Clinical and Experimental Medicine

Volumn 6, Issue 3, 2006, Pages 124-128

  Tanaka, H ^a   Maeshima, S ^a   Shigekawa, Y ^a   Ueda, H ^a   Hamagami, H ^a   Kida, Y ^a   Ichinose, M ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

CBF; Chronic hepatitis; Interferon; Neuropsychological impairment; SPECT

Indexed keywords

ALPHA INTERFERON; ALPHA2B INTERFERON;

ADULT; AGED; ARTICLE; BRAIN BLOOD FLOW; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; MEMORY; MENTAL DISEASE; MINI MENTAL STATE EXAMINATION; NEUROLOGIC DISEASE; NEUROPSYCHOLOGY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL LOBE;

AGED; ANTIVIRAL AGENTS; CEREBROVASCULAR CIRCULATION; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B; INTERFERON-ALPHA; MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS;

HEPATITIS C VIRUS;

EID: 33750294801     PISSN: 15918890     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10238-006-0107-6     Document Type: Article

References (24)

1. Mulhall BP, Younossi Z (2005) Impact of adherence on the outcome of antiviral therapy for chronic hepatitis C. J Clin Gastroenterol 39:S23-S27
2. Loftis JM, Hauser P (2004) The phenomenology and treatment of interferon-induced depression. J Affect Disord 82:175-190
3. Crone CC, Gabriel GM, Wise TN (2004) Managing the neuropsychiatric side effects of interferon-based therapy for hepatitis C. Cleve Clin J Med 71:S27-S32
4. 133Xe inhalation method. Seisin Igaku 32:751-757 (Abstract in English)
5. Kanaya T, Yonekawa M (1990) Regional cerebral blood flow in depression. Jpn J Psychiatry Neurol 44:571-576
6. 133Xe inhalation single photon emission computerized tomography in manic-depressive illness. Jpn J Clin Med N52:1180-1184 (Abstract in English)
7. Folstein MF, Folstein SE, Mchugh PR (1975) Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:182-198
8. Kaneko M (1990) Dementia and frontal lobe function. Higher Brain Funct Res (Tokyo) 10:127-131
9. Saito T, Kato M, Kashima H (1992) Frontal lobe injury and word fluency. Higher Brain Funct Res (Tokyo) 12:223-231
10. Lezak MD (1983) Neuropsychological assessment. Oxford, New York, p 422
11. Raven JC (1976) Coloured progressive matrices. Oxford Psychologists Press Ltd, London
12. Takeuchi R, Yonekura Y, Katayama S, Takeda N, Fujita K, Konishi J (2003) Fully automated quantification of regional cerebral blood flow with three-dimensional stereotaxic region of interest template: validation using magnetic resonance imaging. Neural Med Chir (Tokyo) 43:153-162
13. Swartz BE, Halgren E, Fuster JM, Simpkins E, Gee M, Mandelkern M (1995) Cortical metabolic activation in human during a visual memory task. Cereb Cortex 5:205-214
14. Olson IR, Moore KS, Stark M, Chatterjee A (2006) Visual working memory is impaired when the medical temporal is damaged. J Cogn Neurosci 18:1087-1097
15. Gold JJ, Smith CN, Bayley PJ, Shrager Y, Brewer JB, Stark CE, Hopkins RO, Squire LR (2006) Item memory, source memory, and the medical temporal lobe: concordant findings from fMRI and memory-impaired patient. Proc Natl Acad Sci USA 103:9351-9356
16. Schaefer M, Engelbrecht MA, Gut O, Fiebich BL, Bauer J, Schmidt F, Grunze H, Lieb K (2002) Interferon alpha (IFNa) and psychiatric syndromes: a review. Prog Neuropsychopharmacol Biol Psychiatry 26:731-746
17. Valentine AD, Meyers CA, Kling MA, Richelson E, Hauser P (1998) Mood and cognitive side effects of interferon-alpha therapy. Semin Oncol 25:39-47
18. Schaefer M, Schwaiger M, Garkisch AS, Pich M, Hinzpeter A, Uebelhack R, Heinz A, von Boemmel F, Berg T (2005) Prevention of interferon-alpha associated depression in psychiatric risk patients with chronic hepatitis C. J Hepatol 42:793-798
19. Scheibel RS, Valentine AD, O'Brien S, Meyers CA (2004) Cognitive dysfunction and depression during treatment with interferon-alpha and chemotherapy. J Neuropsychiatry Clin Neurosci 16:185-191
20. Bolwing TG (1993) Regional cerebral blood flow in affective disorder. Acta Psychiatry Scand Suppl 371:48-53
21. Futami H, Chuuman T, Naoi T, Sawada A, Shigehira M, Tubouti H (1994) Ocular complications during systemic interferon therapy. Jpn J Clin Ophthalmol 48:533-537
22. Brouty-Boye D, Zetter BR (1980) Inhibition of cell motility by interferon. Science 208:516-518
23. Sonnenblick M, Rosin A (1991) Cardiotoxicity of interferon: a review of 44 cases. Chest 99:557-561
24. Herbert JE, Savi P, Laplace M-CI, Lale A, Dol F, Labit C, Minty A (1993) IL-4 and IL-13 exhibit comparable abilities to reduce pyrogen-induced expression of procoagulant in endothelial cells and monocutes. FEBS Lett 328:268-270